1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. MERCK & CO INC
135.55 2.63 (1.98%)
8.9M
XNYS Volume

XNYS 13 Aug, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Analyst Upgrade
Daiwa Capital upgrades Merck & Co to an 'Outperform' rating; raises the target price to $143 See details

Merck & Company - MRK - stock price prediction, stock price target, analyst ratings from 28 analysts

Merck & Company has a share price target of US$ 138, revenue growth forecast of 3.3%, and profit growth estimate of -82.1% for FY26, based on top 28 analyst calls.